Latest Insider Transactions at Perrigo CO PLC (PRGO)
This section provides a real-time view of insider transactions for Perrigo CO PLC (PRGO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PERRIGO Co plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PERRIGO Co plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2023
|
Grainne Quinn EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,636
+8.95%
|
$100,168
$38.75 P/Share
|
|
Mar 03
2023
|
Grainne Quinn EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,419
+27.15%
|
$205,922
$38.75 P/Share
|
|
Dec 16
2022
|
Grainne Quinn EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,368
-20.62%
|
$73,408
$31.65 P/Share
|
|
Oct 07
2022
|
Alison Ives EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
217
-4.36%
|
$8,246
$38.09 P/Share
|
|
Oct 07
2022
|
Alison Ives EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+12.94%
|
$28,082
$38.09 P/Share
|
|
May 17
2022
|
Jeffrey B Kindler Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,168
-18.03%
|
$120,384
$38.57 P/Share
|
|
May 17
2022
|
Jeffrey B Kindler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,599
+27.3%
|
$250,762
$38.57 P/Share
|
|
May 17
2022
|
Geoffrey M. Parker Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,168
-21.36%
|
$120,384
$38.57 P/Share
|
|
May 17
2022
|
Geoffrey M. Parker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,599
+30.8%
|
$250,762
$38.57 P/Share
|
|
May 17
2022
|
Bradley A Alford Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,168
-10.36%
|
$120,384
$38.57 P/Share
|
|
May 17
2022
|
Bradley A Alford Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,599
+17.75%
|
$250,762
$38.57 P/Share
|
|
May 17
2022
|
Theodore R. Samuels Ii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,599
+19.82%
|
$250,762
$38.57 P/Share
|
|
May 17
2022
|
Orlando D Ashford Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,168
-38.87%
|
$120,384
$38.57 P/Share
|
|
May 17
2022
|
Orlando D Ashford Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,599
+44.74%
|
$250,762
$38.57 P/Share
|
|
May 17
2022
|
Erica L Mann Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,432
-27.93%
|
$130,416
$38.57 P/Share
|
|
May 17
2022
|
Erica L Mann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,599
+34.94%
|
$250,762
$38.57 P/Share
|
|
May 17
2022
|
Donal O'Connor Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,168
-15.8%
|
$120,384
$38.57 P/Share
|
|
May 17
2022
|
Donal O'Connor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,599
+24.76%
|
$250,762
$38.57 P/Share
|
|
May 17
2022
|
Katherine C. Doyle Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,168
-33.24%
|
$120,384
$38.57 P/Share
|
|
May 17
2022
|
Katherine C. Doyle Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,599
+40.91%
|
$250,762
$38.57 P/Share
|
|
May 17
2022
|
Adriana Karaboutis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,168
-18.59%
|
$120,384
$38.57 P/Share
|
|
May 17
2022
|
Adriana Karaboutis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,599
+27.91%
|
$250,762
$38.57 P/Share
|
|
Apr 05
2022
|
Raymond Silcock EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,467
-2.41%
|
$52,812
$36.27 P/Share
|
|
Apr 05
2022
|
Raymond Silcock EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,963
+6.1%
|
$142,668
$36.27 P/Share
|
|
Mar 14
2022
|
Thomas Farrington EVP and CIO |
SELL
Open market or private sale
|
Indirect |
2,259
-100.0%
|
$83,583
$37.23 P/Share
|
|
Mar 14
2022
|
Thomas Farrington EVP and CIO |
SELL
Open market or private sale
|
Direct |
24,485
-100.0%
|
$905,945
$37.13 P/Share
|
|
Mar 07
2022
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
SELL
Open market or private sale
|
Direct |
3,954
-20.13%
|
$142,344
$36.73 P/Share
|
|
Mar 04
2022
|
Svend Andersen EVP & President CHCI |
SELL
Payment of exercise price or tax liability
|
Direct |
1,289
-0.93%
|
$47,693
$37.23 P/Share
|
|
Mar 04
2022
|
Svend Andersen EVP & President CHCI |
BUY
Exercise of conversion of derivative security
|
Direct |
8,911
+7.17%
|
$329,707
$37.23 P/Share
|
|
Mar 04
2022
|
Svend Andersen EVP & President CHCI |
BUY
Grant, award, or other acquisition
|
Direct |
14,503
+30.08%
|
$536,611
$37.23 P/Share
|
|
Mar 04
2022
|
Raymond Silcock EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,628
-5.03%
|
$319,236
$37.23 P/Share
|
|
Mar 04
2022
|
Raymond Silcock EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,502
+6.91%
|
$314,574
$37.23 P/Share
|
|
Mar 04
2022
|
Raymond Silcock EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,422
+25.38%
|
$718,614
$37.23 P/Share
|
|
Mar 04
2022
|
Murray S Kessler CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
52,595
-10.88%
|
$1,946,015
$37.23 P/Share
|
|
Mar 04
2022
|
Murray S Kessler CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
49,328
+12.44%
|
$1,825,136
$37.23 P/Share
|
|
Mar 04
2022
|
Murray S Kessler CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,286
+39.35%
|
$2,970,582
$37.23 P/Share
|
|
Mar 04
2022
|
Grainne Quinn EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,135
-10.48%
|
$189,995
$37.23 P/Share
|
|
Mar 04
2022
|
Grainne Quinn EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,862
+10.03%
|
$142,894
$37.23 P/Share
|
|
Mar 04
2022
|
Grainne Quinn EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,008
+32.01%
|
$222,296
$37.23 P/Share
|
|
Mar 04
2022
|
James E Dillard Iii EVP & President CSCA |
SELL
Payment of exercise price or tax liability
|
Direct |
8,300
-8.79%
|
$307,100
$37.23 P/Share
|
|
Mar 04
2022
|
James E Dillard Iii EVP & President CSCA |
BUY
Exercise of conversion of derivative security
|
Direct |
7,002
+9.33%
|
$259,074
$37.23 P/Share
|
|
Mar 04
2022
|
James E Dillard Iii EVP & President CSCA |
BUY
Grant, award, or other acquisition
|
Direct |
11,395
+31.98%
|
$421,615
$37.23 P/Share
|
|
Mar 04
2022
|
Todd W Kingma Executive VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
10,001
-5.47%
|
$370,037
$37.23 P/Share
|
|
Mar 04
2022
|
Todd W Kingma Executive VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,911
+6.22%
|
$329,707
$37.23 P/Share
|
|
Mar 04
2022
|
Todd W Kingma Executive VP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
14,503
+23.83%
|
$536,611
$37.23 P/Share
|
|
Mar 04
2022
|
Orlando D Ashford Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,433
-48.02%
|
$53,021
$37.23 P/Share
|
|
Mar 04
2022
|
Orlando D Ashford Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,984
+50.0%
|
$110,408
$37.23 P/Share
|
|
Mar 04
2022
|
Thomas Farrington EVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,966
-5.02%
|
$183,742
$37.23 P/Share
|
|
Mar 04
2022
|
Thomas Farrington EVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,424
+5.74%
|
$163,688
$37.23 P/Share
|
|
Mar 04
2022
|
Thomas Farrington EVP and CIO |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+22.34%
|
$266,400
$37.23 P/Share
|